DE3872372D1 - Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. - Google Patents

Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.

Info

Publication number
DE3872372D1
DE3872372D1 DE8888309826T DE3872372T DE3872372D1 DE 3872372 D1 DE3872372 D1 DE 3872372D1 DE 8888309826 T DE8888309826 T DE 8888309826T DE 3872372 T DE3872372 T DE 3872372T DE 3872372 D1 DE3872372 D1 DE 3872372D1
Authority
DE
Germany
Prior art keywords
increasing
levels
composition
physical performance
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888309826T
Other languages
English (en)
Other versions
DE3872372T2 (de
Inventor
Francis J Carniglia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3872372D1 publication Critical patent/DE3872372D1/de
Publication of DE3872372T2 publication Critical patent/DE3872372T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
DE8888309826T 1987-12-29 1988-10-19 Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. Expired - Lifetime DE3872372T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/139,288 US4871718A (en) 1987-12-29 1987-12-29 Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair

Publications (2)

Publication Number Publication Date
DE3872372D1 true DE3872372D1 (de) 1992-07-30
DE3872372T2 DE3872372T2 (de) 1992-12-10

Family

ID=22485942

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198888309826T Pending DE324227T1 (de) 1987-12-29 1988-10-19 Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
DE8888309826T Expired - Lifetime DE3872372T2 (de) 1987-12-29 1988-10-19 Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE198888309826T Pending DE324227T1 (de) 1987-12-29 1988-10-19 Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.

Country Status (12)

Country Link
US (2) US4871718A (de)
EP (1) EP0324227B1 (de)
JP (1) JPH01175939A (de)
AT (1) ATE77557T1 (de)
AU (1) AU600139B2 (de)
CA (1) CA1325593C (de)
DE (2) DE324227T1 (de)
DK (1) DK726088A (de)
ES (1) ES2045141T3 (de)
GR (1) GR900300016T1 (de)
IE (1) IE62263B1 (de)
NZ (1) NZ225106A (de)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
IT1247125B (it) * 1991-03-01 1994-12-12 Depha Team Srl Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco.
US5195940A (en) * 1991-06-20 1993-03-23 Iatromed, Inc. Method for increased production of growth factor in living tissue using an applied fluctuating magnetic field
AP387A (en) * 1991-09-13 1995-07-31 Siegbert Heinrich Bissbort Therapeutical uses of L-methionine and compositions thereof.
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
EP2327404A1 (de) * 1994-11-08 2011-06-01 Avicena Group, Inc. Verwendung von Kreatinin und Kreatininanaloga zur Behandlung von Erkrankungen des Nervensystems
AU4704596A (en) * 1995-01-20 1996-08-07 Francis J. Carniglia Diet compositions to treat ascites in domestic animals
EP1221615A2 (de) * 1995-04-25 2002-07-10 Oridigm Corporation S-Adenosyl-Methionin-Regulierung in Metabolismen und deren Verwendung in der Diagnostik und Therapie
US5827874A (en) * 1995-05-05 1998-10-27 Meyer; Hans Methods of treating pain and inflammation with proline
US5571518A (en) * 1995-10-30 1996-11-05 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing tricholine citrate
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US8128955B2 (en) * 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US7150880B2 (en) * 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US6218366B1 (en) * 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
GB9814039D0 (en) * 1998-06-29 1998-08-26 Univ London Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury
FR2782270B1 (fr) * 1998-08-12 2001-06-22 Michel Seman Adenosine et nucleotides adenyliques par voie orale pour l'amelioration du travail musculaire
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6479069B1 (en) 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6339716B1 (en) 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
US6335361B1 (en) 1999-11-03 2002-01-01 Juvenon Inc. Method of treating benign forgetfulness
GB2364642B (en) 2000-01-07 2004-10-27 Bioenergy Inc Compositions for enhancing the immune response
KR100338491B1 (ko) * 2000-03-30 2002-05-30 채수경 인중합체로 된 흉터 억제 및 상처 회복 촉진제
US7713546B1 (en) 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US6553254B1 (en) * 2000-04-07 2003-04-22 Keith E. Kenyon Combination of non-living-source physical energy and living-source chemical energy to maximize the salvage of ATP
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
WO2002009727A1 (en) * 2000-07-28 2002-02-07 Bioenergy, Inc. Compositions and methods for improving cardiovascular function
JP2002338473A (ja) * 2001-05-15 2002-11-27 Yaizu Suisankagaku Industry Co Ltd 抗疲労組成物
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
US20040147458A1 (en) * 2002-03-28 2004-07-29 Van Tassel Richard K Compositions to reduce exercise-induced swelling of joints
US20040127428A1 (en) * 2002-12-28 2004-07-01 Kenyon Keith E. Use of D-ribose, including as a topical vehicle, to promote faster healing, including from surgical procedures
US7494643B2 (en) * 2003-07-22 2009-02-24 Rendon Marta I Method and topical composition for the treatment of hyperpigmented skin
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US8105583B2 (en) * 2003-09-29 2012-01-31 Soft Gel Technologies, Inc. Solubilized CoQ-10
AU2005216192B2 (en) * 2004-02-23 2010-11-04 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
US20070191287A1 (en) * 2004-03-18 2007-08-16 Michio Yamamura D-ribose for improving depression-like symptoms
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
WO2005102282A1 (en) 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2005336176A (ja) * 2004-04-28 2005-12-08 Tanabe Seiyaku Co Ltd 肉体疲労改善剤
CA2579962A1 (en) * 2004-08-09 2006-06-01 Enrique Melendez Hevia Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
US20050249803A1 (en) * 2005-06-03 2005-11-10 Udell Ronald G Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
JP5220415B2 (ja) * 2005-09-06 2013-06-26 株式会社明治 老人性貧血を防止又は治療するためのアミノ酸組成物
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US7989009B2 (en) * 2006-02-02 2011-08-02 Advocare International, L.P. Composition and method for promoting weight loss
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss
US7745486B2 (en) * 2006-07-17 2010-06-29 Quercegen Pharma Llc Quercetin-containing compositions
US7745487B2 (en) * 2006-07-17 2010-06-29 Quercegen Pharma Llc Method for enhancing physical performance or immune system recovery from intense physical excercise with quercetin-containing compositions
JP2009037201A (ja) * 2007-03-14 2009-02-19 Fujifilm Corp 感光性樹脂組成物、それを用いた硬化レリーフパターンの製造方法及び半導体装置
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
US20080226696A1 (en) * 2007-03-15 2008-09-18 Ben Treadwell Methods of improving learning abilities of aged companion animals
US20090061016A1 (en) * 2007-09-05 2009-03-05 Selzer Jonathan A Seawater Based Dietary Supplement Product for Energy and Electrolyte Replacement
JP5235439B2 (ja) * 2008-02-06 2013-07-10 丸善製薬株式会社 ＨＭＧ−ＣｏＡ還元酵素産生促進剤
US20090005320A1 (en) * 2008-09-02 2009-01-01 Bruce Kneller Compositions comprising amino acid bicarbonate and methods of use thereof
MX337166B (es) 2009-06-24 2016-02-15 Composicion topica que contiene ibuoprofeno.
EP2445493A1 (de) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topische zusammensetzung mit naproxen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CA2789709C (en) * 2010-02-16 2018-03-20 Viacell, Llc Arginine-containing compositions and methods for treating red blood cells
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
US11389663B2 (en) 2011-04-01 2022-07-19 Bioregentech, Inc. Laser assisted wound healing protocol and system
US11730760B2 (en) 2011-04-01 2023-08-22 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
EP2859889A1 (de) * 2013-10-14 2015-04-15 Abbott Laboratories Zusammensetzungen und Verfahren zur Verbesserung der kognitiven Funktion
WO2017136143A1 (en) 2016-02-01 2017-08-10 Ribocor, Inc. Use of ribose for treatment of subjects having congestive heart failure
WO2018089954A1 (en) 2016-11-10 2018-05-17 BioRegentech Laser assisted wound healing protocol and system
US11654293B2 (en) * 2016-11-10 2023-05-23 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
US20210100347A1 (en) * 2018-01-25 2021-04-08 Se In Oh Toothbrush comprising bristles having different lengths
BR112021010500A2 (pt) 2018-11-30 2021-08-24 Beth Israel Deaconess Medical Center, Inc. Método para reduzir a p-selectina solúvel em um paciente com câncer, método para reduzir ou prevenir a formação de um trombo em um paciente com câncer, método para promover a regressão tumoral em um paciente com câncer, método para estabilizar ou reduzir o câncer metastático em um paciente com câncer, composição farmacêutica para reduzir a p-selectina solúvel em um paciente com câncer, composição farmacêutica para reduzir ou prevenir a formação de um trombo em um paciente com câncer, composição farmacêutica para promover a regressão tumoral em um paciente com câncer e composição farmacêutica para estabilizar ou reduzir câncer metastático em um paciente com câncer
WO2023135827A1 (ja) * 2022-01-13 2023-07-20 ＮｅＳＡ合同会社 神経変性疾患の進行遅延及び防御剤

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2417841A (en) * 1944-06-21 1947-03-25 Frances R Ruskin Nucleotide compounds of components of vitamin b complex
US2844514A (en) * 1953-11-04 1958-07-22 Pabst Brewing Co Process for the production of nucleotides
US3009859A (en) * 1958-07-22 1961-11-21 Laborit Henri Potassium aspartate and magnesium aspartate fatigue-recovery promoting process and compositions
US3104203A (en) * 1959-12-09 1963-09-17 Union Carbide Corp Composition of matter containing procaine adenylate
US3157635A (en) * 1960-08-05 1964-11-17 Takeda Chemical Industries Ltd Sulfonic acid cation exchange resin purification of nucleotides
DE1442304A1 (de) * 1962-08-08 1970-01-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Purinderivaten
US3329567A (en) * 1963-09-16 1967-07-04 Union Carbide Corp Synergistic effect of adenylic nucleotides in digitalis therapy
DE1692496A1 (de) * 1965-01-27 1971-08-05 Takeda Chemical Industries Ltd Futtermittel
US3931402A (en) * 1970-12-02 1976-01-06 Societa Prodotti Antibiotici S.P.A. Preparations containing hexoses
FR2129833B1 (de) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
US3819830A (en) * 1971-07-01 1974-06-25 Dainippon Pharmaceutical Co Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
US3978213A (en) * 1972-07-10 1976-08-31 Nelson Research & Development Company Cosmetic use of cyclic amp and phosphodiesterase inhibitors
ZA7469B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferative skin diseases with-c-amp analogs
US4211770A (en) * 1973-01-16 1980-07-08 The Upjohn Company Treatment of psoriasis intralesionally with N6 -2'-O-dibutyryl cyclic AMP
US3988466A (en) * 1973-06-01 1976-10-26 Kyowa Hakko Kogyo Co., Ltd. Prevention of gastric lesions
DE2509531A1 (de) * 1975-03-05 1976-09-16 Thomae Gmbh Dr K Antivirales mittel
US4363818A (en) * 1975-06-04 1982-12-14 Gottlieb Sheldon K Method for relief of burning, itching, and pain of cutaneous and mucosal surfaces
US4126701A (en) * 1975-10-24 1978-11-21 A.H.P., Inc. Process of sparing poultry from the effect of toxins
US4078971A (en) * 1976-03-31 1978-03-14 Temple University Bound, active cellular organelles and method of producing same
US4207315A (en) * 1976-10-20 1980-06-10 University Patents, Inc. Process for treating proliferative skin diseases using certain diamino compounds
US4414202A (en) * 1980-02-19 1983-11-08 Silvetti Anthony N Composition for treatment of wounds
US4308257A (en) * 1980-06-03 1981-12-29 Saul Caspe Accelerating cellular repair composition for the human body and method of administering same
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4546095A (en) * 1980-07-21 1985-10-08 Markov Angel K Use of fructose-1,6-diphosphate for treating myocardial infarction
FR2489145A1 (fr) * 1980-09-04 1982-03-05 Geistlich Soehne Ag Compositions pharmaceutiques accelerant la guerison de blessures
US4362745A (en) * 1980-11-19 1982-12-07 Johnston Frederick B Medical process and preparation
WO1982003552A1 (en) * 1981-04-17 1982-10-28 Hospital Supply Corp American Improved solution for parenteral nutrition
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
JPS58129970A (ja) * 1982-01-26 1983-08-03 Kazutomo Imahori アデノシン三リン酸変換用装置
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
DE3578124D1 (de) * 1984-01-18 1990-07-19 Oehmke Martin Niedrig osmotisches hypokalorisches waessriges praeparat fuer die infusion.
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
DE3684564D1 (de) * 1985-11-18 1992-04-30 Beecham Group Plc Veterinaere zusammensetzungen.
US4923851A (en) * 1987-12-29 1990-05-08 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4945087A (en) * 1988-03-31 1990-07-31 Warner-Lambert Company Taste masking of thymol
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4983394A (en) * 1990-05-03 1991-01-08 Warner-Lambert Company Flavor enhancing and medicinal taste masking agent

Also Published As

Publication number Publication date
US4871718A (en) 1989-10-03
NZ225106A (en) 1990-10-26
ATE77557T1 (de) 1992-07-15
EP0324227B1 (de) 1992-06-24
CA1325593C (en) 1993-12-28
JPH01175939A (ja) 1989-07-12
IE882583L (en) 1989-06-29
ES2045141T3 (es) 1994-01-16
JPH0520414B2 (de) 1993-03-19
AU1769088A (en) 1989-06-29
EP0324227A1 (de) 1989-07-19
IE62263B1 (en) 1995-01-11
DE3872372T2 (de) 1992-12-10
AU600139B2 (en) 1990-08-02
GR900300016T1 (en) 1991-06-07
DK726088A (da) 1989-06-30
DK726088D0 (da) 1988-12-28
DE324227T1 (de) 1989-11-16
US5391550A (en) 1995-02-21

Similar Documents

Publication Publication Date Title
DE3872372D1 (de) Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
SE8505112D0 (sv) Novel pharmacological compounds
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
ATE69548T1 (de) Vitamin e-haltiges mittel zur verbesserung der eigenschaften des blutes.
IT8620902A0 (it) Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
NO893135D0 (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
NO874892D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
IE44034L (en) Pyrrolidone carboxylic acids.
ATE58521T1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
DE3869522D1 (de) Herstellung von (3s,4s)-(n-alpha-boc)-4-amino-5-cyclohexyl-3-hydroxypentansaeureethylester.
RO96600A2 (ro) Compimat medicamentos tamponat,destinat tratamentului carentelor de zinc
ATE97574T1 (de) Arzneimittelzusammensetzung, enthaltend deoxyribonukleoside fuer heilung von wunden.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee